Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
125.88
-31.48 (-20.01%)
At close: Feb 21, 2025, 4:00 PM
126.30
+0.42 (0.33%)
After-hours: Feb 21, 2025, 4:43 PM EST
Glaukos Employees
Glaukos had 907 employees as of December 31, 2023. The number of employees increased by 124 or 15.84% compared to the previous year.
Employees
907
Change (1Y)
124
Growth (1Y)
15.84%
Revenue / Employee
$422,802
Profits / Employee
-$161,380
Market Cap
6.94B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 907 | 124 | 15.84% |
Dec 31, 2022 | 783 | 56 | 7.70% |
Dec 31, 2021 | 727 | 74 | 11.33% |
Dec 31, 2020 | 653 | 53 | 8.83% |
Dec 31, 2019 | 600 | 163 | 37.30% |
Dec 31, 2018 | 437 | 50 | 12.92% |
Dec 31, 2017 | 387 | 123 | 46.59% |
Dec 31, 2016 | 264 | 82 | 45.05% |
Dec 31, 2015 | 182 | 56 | 44.44% |
Dec 31, 2014 | 126 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
GKOS News
- 1 day ago - Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition - Benzinga
- 1 day ago - Glaukos Corporation (GKOS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 4 weeks ago - Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20 - Business Wire
- 5 weeks ago - Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform - Business Wire
- 7 weeks ago - Glaukos To Rally Around 17%? Here Are 6 Top Analyst Forecasts For Tuesday - Benzinga
- 2 months ago - Glaukos Submits New Drug Application to U.S. FDA for Epioxa™ - Business Wire
- 2 months ago - Glaukos: Still Bullish, But Embedded Expectations Are Now High - Seeking Alpha